戻る Agenda
DA01: Current and Future Status of Drug Development in Japan, the US, and Europe under COVID-19 Pandemic
Session Chair(s)
Hironobu Saito, PhD
Specially Appointed Professor
Tottori University, Chromosome Egineering Research Center, Japan
Junko Sato, PhD
Associate Executive Director
Pharmaceuticals and Medical Devices Agency (PMDA), Japan